Early Access — free while we kick the tires
EdgarHawk

Klausner Richard

Director

Director
1 filing analyzed · 1 company · Latest 2025-03-18

Never miss a filing from Klausner Richard

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Lyell Immunopharma, Inc. LYEL 1 0 Net buying

Activity

March 2025
high
Buy
158,000 shares
$94,942
Significance 6/10

Director Klausner buys 158,000 LYEL shares at $0.60; stock now $9.67, -83.9% from 52-week high; cluster pattern with 2 other insiders in 14 days.

Richard Klausner, a director, purchased 158,000 shares at $0.60 on 2025-03-14, increasing his holdings by 23.1% to 843,365 shares. This purchase occurs amid significant price deterioration: the stock has fallen -20.8% over the past 30 days and -83.9% from its 52-week high of $60.20. A cluster pattern is present, with 2 other insiders also buying within the past 14 days. The company's fundamentals remain deeply challenged—quarterly revenue was $34,000.00 while net income was $-44,583,000.00, and annual revenue contracted -53.1% year-over-year. The combination of substantial insider accumulation during a steep drawdown, alongside coordinated purchasing by other board members, warrants examination of whether this reflects conviction in near-term recovery or represents a response to other factors.

Related insiders